Shared on 05 Nov 25
Fair value Decreased 1.36%Analysts have lowered their fair value price target for Philip Morris International from $188.00 to $185.44, citing slightly softer revenue growth and profit margin expectations. However, they note that the recent share pullback provides an attractive buying opportunity in light of overall positive business performance.
Shared on 21 Oct 25
Fair value Decreased 1.16%Analysts Assess Philip Morris Pullback as Valuation Adjusts After Company Guidance and Dividend Boost
The analyst price target for Philip Morris International has been revised slightly downward from $190.20 to $188.00, as analysts cite moderating profit margin and revenue growth expectations. Analysts also note that recent share price weakness may present a buying opportunity.
Shared on 27 Aug 25
Fair value Increased 1.98%Smoke-Free Alternatives Will Drive Global Opportunity In Emerging Markets
Analysts have raised their price target for Philip Morris International to $190.20, citing expectations for strong Q2 performance driven by growth in ZYN and IQOS, potential upward financial guidance revisions, and ongoing strength in both smoke-free and traditional products. Analyst Commentary Bullish analysts anticipate impressive Q2 delivery across all business segments, highlighting strong ZYN volumes and robust contributions from both IQOS and traditional combustible products.
Shared on 07 May 25
Fair value Increased 9.32%Smoke-Free Alternatives Will Drive Global Opportunity In Emerging Markets
Shared on 30 Apr 25
Fair value Increased 8.90%ZYN And IQOS Will Expand Global Market Opportunities
AnalystConsensusTarget has increased revenue growth from 7.0% to 7.9%.
Shared on 23 Apr 25
Fair value Decreased 0.32%ZYN And IQOS Will Expand Global Market Opportunities
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 16 Apr 25
Fair value Increased 1.97%ZYN And IQOS Will Expand Global Market Opportunities
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 09 Apr 25
Fair value Increased 1.70%ZYN And IQOS Will Expand Global Market Opportunities
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 02 Apr 25
Fair value Increased 1.23%ZYN And IQOS Will Expand Global Market Opportunities
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 26 Mar 25
ZYN And IQOS Will Expand Global Market Opportunities
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 19 Mar 25
ZYN And IQOS Will Expand Global Market Opportunities
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 17 Mar 25
Fair value Increased 0.45%ZYN And IQOS Will Expand Global Market Opportunities
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 10 Mar 25
Fair value Decreased 19%ZYN And IQOS Will Expand Global Market Opportunities
AnalystConsensusTarget has increased future PE multiple from 20.0x to 22.1x.

